未登录

M

Murielle Girard

centre hospitalier esquirol

H指数:19

被引数:894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Personality traits and craving in patients undergoing alcohol withdrawal treatment

人格特质和渴求在酒精戒断治疗中的患者

Journal of Psychiatric Research

IF3.2

2025-10-300

OAAI

Liver fibrosis evaluation in patients with psychiatric diseases

精神疾病患者的肝脏纤维化评估

Clinics and Research in Hepatology and Gastroenterology

IF2.4

2025-06-180

PRE

Epidemiology of alcohol use disorder in the general population of Togo and Benin: the ALCOTRANS study

BMC PUBLIC HEALTH

IF3.6

2024-06-060

OAAI

Alcohol Use Disorder in the General Population in Sub-Saharan Africa

NEUROEPIDEMIOLOGY

IF4

2023-10-253

OA

BDNF CpG methylation and serum levels covary during alcohol withdrawal in patients with alcohol use disorder: A pilot study

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

IF3.8

2023-08-090

PRE

Sensory processing in depression: Assessment and intervention perspective

CLINICAL PSYCHOLOGY & PSYCHOTHERAPY

IF2.7

2022-10-0612

PRE

Psychomotor semiology in depression: a standardized clinical psychomotor approach

IF3.6

2022-07-154

OAAI

Effectiveness of Repetitive Transcranial Magnetic Stimulation on Fibromyalgia Patients Responding to a First Repetitive Transcranial Magnetic Stimulation Induction Course After Six Months of Maintenance Treatment: A Randomized Pilot-Controlled Study

NEUROMODULATION

IF3.5

2022-06-016

OAAI

Predictors of clinical response after rTMS treatment of patients suffering from drug-resistant depression

TRANSLATIONAL PSYCHIATRY

IF6.2

2021-11-1517

OAAI

BDNF and pro-BDNF in serum and exosomes in major depression: Evolution after antidepressant treatment

重度抑郁症患者血清和外泌体中的BDNF和pro-bdnf: 抗抑郁治疗后的演变

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2021-07-0171

OAAI

Acceptability of Pharmacogenetic Testing among French Psychiatrists, a National Survey

法国精神科医生对药物遗传学测试的可接受性，一项全国性调查

JOURNAL OF PERSONALIZED MEDICINE

IF3

2021-05-2112

OAAI

Overview of the means of communications used by users of a french psychiatric hospital centre : digital or social divide ?

EUROPEAN PSYCHIATRY

IF6.7

2020-04-170

PREAI

Management of alcohol usage disorder: lessons from clinical research data

EUROPEAN PSYCHIATRY

IF6.7

2020-04-150

PREAI

Variation in serum level markers of neuronal integrity and inflammation of alcohol-dependent subjects after weaning

EUROPEAN PSYCHIATRY

IF6.7

2020-04-150

PREAI

Predictive response factors of repetitive transcranial magnetic stimulation in treatment-resistant depression

EUROPEAN PSYCHIATRY

IF6.7

2020-03-230

PREAI

Evolution of BDNF serum levels during the first six months after alcohol withdrawal

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

IF3.8

2020-03-0612

PREAI

Serum inflammatory molecules and markers of neuronal damage in alcohol-dependent subjects after withdrawal

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

IF3.8

2017-07-3116

PREAI

Laterality and Lateralization in Autism Spectrum Disorder, Using a Standardized Neuro-Psychomotor Assessment

DEVELOPMENTAL NEUROPSYCHOLOGY

IF2.2

2017-02-1022

PREAI

A prospective hospital study of alcohol use disorders, comorbid psychiatric conditions and withdrawal prognosis

general psychiatry

IF3.1

2016-08-319

OAAI

rTMS for pharmacoresistant major depression in the clinical setting of a psychiatric hospital: Effectiveness and effects of age

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2013-09-0128

PREAI